(Chiyoda-ku, Tokyo; CEO: Takanori Kobayashi; hereinafter "New Space"), a company that promotes corporate health management and productivity improvement through "sleep technology" funded and supported by Glocalink Corporation (Shinjuku-ku, Tokyo; CEO: Kazuhiro Hasegawa; hereinafter "Glocalink"), and iCARE Co. (Shibuya-ku, Tokyo; CEO: Yota Yamada; hereafter "iCARE"), operator of Carely, have entered into a business alliance agreement to provide sleep improvement programs to companies.

The "My Sommnie" program, which aims to further improve sleep by combining the medical knowledge and expertise on sleep of Neurospace's sleep training with health checkups via chats conducted by the expert staff of the "Carely" system operated by iCARE, is being offered today. The new program, "My Sommnie", is designed to further improve sleep quality. This program aims to further improve the sleep environment of companies by providing individual consultation for concerns, something that has been impossible to achieve in the corporate training programs offered by Neurospace.
■Outline of "My Sommnie
Employee Sleep Problems Are Reducing Company Productivity
My Sommnie is a corporate program to improve the quality of sleep for working people. The program helps people improve their sleep techniques by learning about their sleep type and the sleep knowledge and response methods that are appropriate for them. https://www.icare.jpn.com/mysommnie/

■About Neurospace, Inc.
Founded: December 2013 Representative Director: Takanori Kobayashi
In addition to improving the sleep of many employees by making sleep a key component of corporate health management, we are developing EEG sensing technology and biometric signal processing technology for simple measurement and visualization of sleep conditions through an industry-academia collaboration with the University of Tsukuba.
URL: http://neurospace.jp/

Since 2012, Glocalink has been investing in and fostering the development of prototypes for companies that are the recipients of the TECH PLANTER seed acceleration program run by its parent company, LIVERNESS Corporation. GLOCA-LINK will continue to find companies to support through TECH PLANTER, which will be held again this year.
TECH PLANTER Home Page　https://techplanter.com/
In addition, Neurospace Inc. received the Rohto Award from Rohto Pharmaceutical Co., Ltd. in the 3rd TECH PLAN Grand Prix (now Deep Tech Grand Prix).